Academic Health Science Network

Academic Health Science Network
Name	Academic Health Science Network
Type	Network of health innovation organisations
Founded	2013
Headquarters	United Kingdom
Region served	England

Academic Health Science Network

The Academic Health Science Network is a collective of regional National Health Service innovation networks established to accelerate the adoption of clinical innovations across health systems. It links academic institutions such as University of Oxford, University of Cambridge, University College London, and King's College London with clinical providers including Guy's and St Thomas' NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust, Manchester University NHS Foundation Trust, and industry partners such as GlaxoSmithKline, AstraZeneca, Novo Nordisk. The initiative interacts with policy bodies like Department of Health and Social Care, regulatory agencies such as the Medicines and Healthcare products Regulatory Agency, and funders including National Institute for Health and Care Research.

History

The origins trace to policy reforms and health innovation strategies promoted during the Coalition government (United Kingdom) era and implementation periods overlapping with the Health and Social Care Act 2012. Early pilots engaged with academic centres like Imperial College London, University of Edinburgh, University of Manchester, and teaching hospitals exemplified by Royal Free London NHS Foundation Trust and Cambridge University Hospitals NHS Foundation Trust. The Networks evolved through partnerships with innovation actors such as Wellcome Trust, Innovate UK, Medical Research Council, and philanthropic organisations including Gates Foundation and Wellcome. Major milestones included engagement with national programmes led by NHS England and coordinated efforts during public health events such as the COVID-19 pandemic in the United Kingdom.

Structure and governance

Each regional network is hosted or partnered with higher education institutions like University of Leeds, University of Liverpool, Queen Mary University of London, and hospital trusts such as Barts Health NHS Trust and Leeds Teaching Hospitals NHS Trust. Governance arrangements reference statutory regulators such as Care Quality Commission and interact with strategic bodies including Health Education England and the National Institute for Health and Care Excellence. Leadership roles often include academics with appointments at institutions like University of Bristol and Newcastle University and executives seconded from trusts like Oxford University Hospitals NHS Foundation Trust. Board membership commonly involves representatives from charities such as British Heart Foundation, industry partners like Roche, and clinical networks such as Royal College of Physicians.

Functions and activities

Typical activities span technology adoption, service redesign, and knowledge translation connecting innovators from UCL Partners and the Oxford Academic Health Science Network-style hubs with commissioners from Clinical Commissioning Group predecessors and current commissioners associated with Integrated Care Systems. Projects include digital health pilots involving companies such as Philips, Siemens Healthineers, and start-ups from accelerators like Cambridge Enterprise. The Networks run programmes for patient safety aligned with guidelines from National Institute for Health and Care Excellence and quality improvement initiatives tied to professional bodies including Royal College of Nursing and Royal College of General Practitioners.

Partnerships and collaborations

Partnerships extend to universities such as University of Southampton, University of Glasgow, Cardiff University, and international collaborators like World Health Organization and agencies such as European Commission. Collaborations with industry include pharmaceutical firms (Pfizer, Johnson & Johnson), medical device manufacturers (Stryker, Medtronic), and digital health firms including Babylon Health and DeepMind. The Networks coordinate with national research infrastructures such as Clinical Practice Research Datalink and trial networks affiliated with Health Innovation Network. They also partner with charities like Macmillan Cancer Support and Alzheimer's Society and workforce bodies including General Medical Council.

Impact and evaluation

Evaluations reference metrics used by bodies such as National Institute for Health and Care Excellence and funders like Wellcome Trust and Innovate UK. Reported impacts include accelerated diffusion of innovations showcased by collaborations with Royal College of Surgeons projects, roll-outs of digital pathways piloted with NHSX, and cost-effectiveness analyses involving health economists from London School of Economics and University of York. Impact assessments have been cited in policy discussions involving House of Commons Health and Social Care Committee and studies led by academic groups at King's College London and University of Birmingham.

Funding and resources

Core funding streams have included grants and contracts from NHS England, competitive awards from Innovate UK, research funding via National Institute for Health and Care Research, and philanthropic contributions from organisations like Wellcome Trust. In-kind support often comes from university partners such as University of Nottingham and hospital trusts including Sheffield Teaching Hospitals NHS Foundation Trust. Commercial income arises through partnerships with firms like GSK Vaccines and consultancy arrangements with technology vendors such as Cerner.

Criticisms and controversies

Critiques have emerged in parliamentary inquiries and commentaries involving organisations like Kings Fund and academics from London School of Hygiene & Tropical Medicine concerning overlap with existing structures including Academic Health Science Centres, potential conflicts of interest with industry partners like Pfizer and Roche, and variability in regional performance exemplified by differing outcomes in areas served by Wessex AHSN and Yorkshire and Humber AHSN. Debates have involved regulators such as National Audit Office and watchdog reports referencing procurement transparency and accountability in commissioning contexts associated with Clinical Commissioning Group predecessors.

Category:Health care networks